ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) is one of the deadliest malignancies worldwide, with late detection, ineffective treatment and poor overall survival. Immunotherapy, including immune checkpoint inhibitor (ICI) therapy, holds great potential for treatment of HCC. Although some patients respond...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyao Hu (Author), Dan Li (Author), Hua Zhu (Author), Tao Yu (Author), Xiaoxing Xiong (Author), Ximing Xu (Author)
Format: Book
Published: BMC, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available